Cassava Sciences, Inc. (SAVA)
USD 1.34
(5.51%)
USD 1.34
(5.51%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -89.42 Million USD | -6763.91% |
| 2022 | -1.3 Million USD | -143.97% |
| 2021 | -534 Thousand USD | -54.34% |
| 2020 | -346 Thousand USD | -496.55% |
| 2019 | -58 Thousand USD | 15.94% |
| 2018 | -69 Thousand USD | -1.47% |
| 2017 | -68 Thousand USD | -17.24% |
| 2016 | -58 Thousand USD | -28.89% |
| 2015 | -45 Thousand USD | -515.93% |
| 2014 | -7306.00 USD | -100.02% |
| 2013 | 41.11 Million USD | 277.8% |
| 2012 | 10.88 Million USD | -5.24% |
| 2011 | 11.48 Million USD | -31.68% |
| 2010 | 16.8 Million USD | -18.26% |
| 2009 | 20.56 Million USD | -67.73% |
| 2008 | 63.72 Million USD | -3.42% |
| 2007 | 65.98 Million USD | 22.38% |
| 2006 | 53.91 Million USD | 961.38% |
| 2005 | 5.08 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 114 Thousand USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 6.15 Million USD | 300.12% |
| 1999 | 1.53 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -300 Thousand USD | 3.54% |
| 2024 Q1 | -311 Thousand USD | -115.61% |
| 2023 Q2 | -391 Thousand USD | 0.0% |
| 2023 Q3 | -392 Thousand USD | -0.26% |
| 2023 Q4 | 1.99 Million USD | 608.16% |
| 2023 FY | -1.53 Million USD | -17.44% |
| 2023 Q1 | -391 Thousand USD | -0.05% |
| 2022 Q3 | -300 Thousand USD | -0.33% |
| 2022 FY | -1.3 Million USD | -143.97% |
| 2022 Q1 | -313 Thousand USD | 0.06% |
| 2022 Q4 | -390.8 Thousand USD | -30.27% |
| 2022 Q2 | -299 Thousand USD | 4.47% |
| 2021 Q3 | -212 Thousand USD | -2550.0% |
| 2021 Q2 | -8000.00 USD | -700.0% |
| 2021 Q1 | -1000.00 USD | 99.71% |
| 2021 FY | -534 Thousand USD | -54.34% |
| 2021 Q4 | -313.2 Thousand USD | -47.74% |
| 2020 Q3 | -399.00 USD | 99.84% |
| 2020 FY | -346 Thousand USD | -496.55% |
| 2020 Q2 | -246 Thousand USD | -146.0% |
| 2020 Q1 | -100 Thousand USD | -13450.14% |
| 2020 Q4 | -346 Thousand USD | -86616.79% |
| 2019 Q2 | -308.00 USD | 46.34% |
| 2019 Q4 | -738.00 USD | -1519.23% |
| 2019 Q1 | -574.00 USD | -28600.0% |
| 2019 FY | -58 Thousand USD | 15.94% |
| 2019 Q3 | 52.00 USD | 116.88% |
| 2018 Q4 | -2.00 USD | 99.54% |
| 2018 FY | -69 Thousand USD | -1.47% |
| 2018 Q3 | -436.00 USD | 70.2% |
| 2018 Q2 | -1463.00 USD | -36.99% |
| 2018 Q1 | -1068.00 USD | 30.83% |
| 2017 FY | -68 Thousand USD | -17.24% |
| 2017 Q2 | -3063.00 USD | -120.68% |
| 2017 Q1 | -1388.00 USD | -3.97% |
| 2017 Q3 | -1619.00 USD | 47.14% |
| 2017 Q4 | -1544.00 USD | 4.63% |
| 2016 FY | -58 Thousand USD | -28.89% |
| 2016 Q3 | -2657.00 USD | -67.21% |
| 2016 Q2 | -1589.00 USD | 55.8% |
| 2016 Q4 | -1335.00 USD | 49.76% |
| 2016 Q1 | -3595.00 USD | 0.69% |
| 2015 Q3 | -2356.00 USD | -18.63% |
| 2015 Q2 | -1986.00 USD | -74.52% |
| 2015 Q4 | -3620.00 USD | -53.65% |
| 2015 FY | -45 Thousand USD | -515.93% |
| 2015 Q1 | -1138.00 USD | -2.71% |
| 2014 Q1 | -2147.00 USD | -100.01% |
| 2014 FY | -7306.00 USD | -100.02% |
| 2014 Q3 | -2116.00 USD | -9.35% |
| 2014 Q2 | -1935.00 USD | 9.87% |
| 2014 Q4 | -1108.00 USD | 47.64% |
| 2013 Q2 | 1.95 Million USD | 0.05% |
| 2013 Q1 | 1.95 Million USD | -20.64% |
| 2013 FY | 41.11 Million USD | 277.8% |
| 2013 Q4 | 35.24 Million USD | 1701.27% |
| 2013 Q3 | 1.95 Million USD | -0.07% |
| 2012 Q1 | 2.97 Million USD | 8.23% |
| 2012 Q2 | 2.72 Million USD | -8.38% |
| 2012 Q4 | 2.46 Million USD | -9.43% |
| 2012 FY | 10.88 Million USD | -5.24% |
| 2012 Q3 | 2.72 Million USD | -0.05% |
| 2011 Q3 | 2.74 Million USD | -0.11% |
| 2011 FY | 11.48 Million USD | -31.68% |
| 2011 Q1 | 3.23 Million USD | -59.6% |
| 2011 Q2 | 2.75 Million USD | -14.96% |
| 2011 Q4 | 2.74 Million USD | -0.07% |
| 2010 Q4 | 8 Million USD | 176.65% |
| 2010 Q2 | 2.65 Million USD | -18.25% |
| 2010 Q1 | 3.24 Million USD | -12.87% |
| 2010 FY | 16.8 Million USD | -18.26% |
| 2010 Q3 | 2.89 Million USD | 9.0% |
| 2009 Q3 | 3.76 Million USD | -39.66% |
| 2009 FY | 20.56 Million USD | -67.73% |
| 2009 Q2 | 6.23 Million USD | -8.76% |
| 2009 Q4 | 3.72 Million USD | -0.9% |
| 2009 Q1 | 6.83 Million USD | -17.09% |
| 2008 Q4 | 8.24 Million USD | -72.79% |
| 2008 FY | 63.72 Million USD | -3.42% |
| 2008 Q3 | 30.29 Million USD | 187.23% |
| 2008 Q2 | 10.54 Million USD | -27.95% |
| 2008 Q1 | 14.63 Million USD | 4.15% |
| 2007 Q4 | 14.05 Million USD | -11.09% |
| 2007 Q1 | 22.05 Million USD | 248.07% |
| 2007 Q3 | 15.81 Million USD | 12.41% |
| 2007 Q2 | 14.06 Million USD | -36.22% |
| 2007 FY | 65.98 Million USD | 22.38% |
| 2006 Q4 | 6.33 Million USD | -65.77% |
| 2006 Q2 | 13.74 Million USD | -10.31% |
| 2006 Q3 | 18.51 Million USD | 34.66% |
| 2006 Q1 | 15.32 Million USD | 201.69% |
| 2006 FY | 53.91 Million USD | 961.38% |
| 2005 Q4 | 5.08 Million USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | 5.08 Million USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | -100.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q1 | 125 Thousand USD | 9.65% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | 114 Thousand USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | 114 Thousand USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 Q2 | 1.00 USD | 0.0% |
| 2001 Q1 | 1.00 USD | -100.0% |
| 2001 Q3 | - USD | -100.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | -100.0% |
| 2000 Q4 | 53.66 Thousand USD | -98.41% |
| 2000 Q3 | 3.36 Million USD | 23.85% |
| 2000 FY | 6.15 Million USD | 300.12% |
| 2000 Q2 | 2.71 Million USD | 15321.33% |
| 2000 Q1 | 17.63 Thousand USD | 0.0% |
| 1999 FY | 1.53 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | 164.05% |
| Immix Biopharma, Inc. | -5468.00 USD | -1635287.71% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -13367.319% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -15.239% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -16868.311% |
| MiMedx Group, Inc. | 266.84 Million USD | 133.511% |
| Novavax, Inc. | 639.93 Million USD | 113.974% |
| Seer, Inc. | 7.02 Million USD | 1372.563% |
| Acelyrin, Inc. | -115 Thousand USD | -77659.13% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 166.108% |
| IO Biotech, Inc. | -756 Thousand USD | -11728.439% |
| Ardelyx, Inc. | 106.66 Million USD | 183.839% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 7.764% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -186.91% |
| Fortress Biotech, Inc. | 57.85 Million USD | 254.569% |
| Fortress Biotech, Inc. | 57.85 Million USD | 254.569% |
| Geron Corporation | -123.5 Million USD | 27.594% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 137.146% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 639.44% |
| Incyte Corporation | 3.44 Billion USD | 102.599% |
| Innoviva, Inc. | 261.06 Million USD | 134.253% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -162487.273% |
| ChromaDex Corporation | 50.78 Million USD | 276.099% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 174.673% |
| MEI Pharma, Inc. | 49.32 Million USD | 281.286% |
| NextCure, Inc. | -3.68 Million USD | -2327.334% |
| Onconetix, Inc. | -1.12 Million USD | -7833.444% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -208.696% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -62302.216% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 15.736% |
| Vaxcyte, Inc. | -75 Million USD | -19.231% |
| Precigen, Inc. | 106 Thousand USD | 84461.321% |
| Pharming Group N.V. | 220.1 Million USD | 140.628% |
| ContextLogic Inc. | 59 Million USD | 251.564% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -38444.397% |
| Pyxis Oncology, Inc. | -2 Million USD | -4371.15% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 181.462% |
| AlloVir, Inc. | -398 Thousand USD | -22368.09% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 407.771% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -889592.568% |
| Summit Therapeutics Inc. | -2.05 Million USD | -4262.098% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -745091.667% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -15560.771% |
| Senti Biosciences, Inc. | -2.68 Million USD | -3232.948% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 74619.167% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1763.756% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 406.99% |
| Psyence Biomedical Ltd. | -240.00 USD | -37259483.333% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -202269.422% |
| Chimerix, Inc. | 324 Thousand USD | 27699.691% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -155890.301% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -108952.439% |
| CRISPR Therapeutics AG | 240.95 Million USD | 137.112% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 185.902% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 17463.689% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 8962.537% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2322.075% |
| Precision BioSciences, Inc. | 40.47 Million USD | 320.95% |
| Dyadic International, Inc. | 922.95 Thousand USD | 9788.75% |
| Elevation Oncology, Inc. | -39 Thousand USD | -229189.744% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 524.59% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 174.226% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 105.891% |
| Aptorum Group Limited | -1.11 Million USD | -7922.245% |
| Bicycle Therapeutics plc | -129.52 Million USD | 30.958% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2168.44% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1236.107% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -569.442% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Alkermes plc | 1.37 Billion USD | 106.505% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2142.554% |
| Jaguar Health, Inc. | 7.72 Million USD | 1257.729% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 18128.831% |
| AbCellera Biologics Inc. | 38.02 Million USD | 335.169% |
| PureTech Health plc | -1.6 Million USD | -5478.478% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -17205.02% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -97.293% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 11250.0% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 515.052% |
| AnaptysBio, Inc. | 14.78 Million USD | 704.986% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -290.17% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -75368.179% |
| Molecular Templates, Inc. | 50.39 Million USD | 277.444% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 404.294% |
| Vaxxinity, Inc. | -2.23 Million USD | -3902.82% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -18075.407% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -306.709% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -90.916% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -9321.139% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1788360.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2307.43% |
| ImmuCell Corporation | 4.39 Million USD | 2134.059% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -51044.741% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 21190.33% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 569.585% |
| Opthea Limited | 21.72 Thousand USD | 411808.103% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 50.706% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 8.954% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 8.904% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 14783.58% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 128.508% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 3574.087% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -176137.682% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1159.834% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -18743.945% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -859736.538% |
| Soligenix, Inc. | 97.31 Thousand USD | 91994.03% |
| Century Therapeutics, Inc. | -10.8 Million USD | -727.301% |
| Kura Oncology, Inc. | -849 Thousand USD | -10432.744% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -33.26% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -60731.973% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 190.291% |
| Autolus Therapeutics plc | -4.86 Million USD | -1737.333% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 316.071% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -53127.976% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 194.405% |
| GRI Bio, Inc. | 10.84 Million USD | 924.859% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 3620.61% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -929.389% |
| IGM Biosciences, Inc. | -211.66 Million USD | 57.752% |
| INmune Bio, Inc. | 155 Thousand USD | 57792.258% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 244.373% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5836.635% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -13690.184% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -305369.017% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 22344.527% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -4380.11% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -28469.649% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 194.667% |
| Verastem, Inc. | -62 Thousand USD | -144130.645% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 3772.402% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -34161.686% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 3054.179% |
| Histogen Inc. | 3.76 Million USD | 2472.592% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 15620.003% |
| Surrozen, Inc. | -27.23 Million USD | -228.399% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1559.362% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -7321.735% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -248.668% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 545.956% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -4516213.131% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1574.065% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -133106.715% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 157.77% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 61432.647% |
| Apollomics, Inc. | 127 Thousand USD | 70511.811% |
| Amarin Corporation plc | 165.54 Million USD | 154.019% |
| Mesoblast Limited | -9.81 Million USD | -811.085% |
| Turnstone Biologics Corp. | 16.5 Million USD | 641.761% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 19.066% |
| Synaptogenix, Inc. | -6347.00 USD | -1408801.843% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -175239.216% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 155.417% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 105.088% |
| Better Therapeutics, Inc. | -2.72 Million USD | -3176.768% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 20.273% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 126.45% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -783762.202% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1328.482% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7970.668% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1321.959% |
| Insmed Incorporated | 239.63 Million USD | 137.316% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2599.245% |
| OmniAb, Inc. | 14.66 Million USD | 709.688% |
| Alector, Inc. | -95.05 Million USD | 5.923% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 171.185% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -105.745% |
| Zai Lab Limited | 170.9 Million USD | 152.324% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 209.216% |
| Aura Biosciences, Inc. | -1.29 Million USD | -6805.251% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 68886.923% |
| Immunic, Inc. | -111 Thousand USD | -80461.261% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 664.041% |
| Veracyte, Inc. | 248.14 Million USD | 136.036% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.721% |
| FibroGen, Inc. | 128.9 Million USD | 169.372% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -15855041.844% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -666.469% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.631% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 23087.918% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 125.165% |
| TG Therapeutics, Inc. | 219.1 Million USD | 140.812% |
| Galecto, Inc. | -830 Thousand USD | -10673.855% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -6356.534% |
| Fortrea Holdings Inc. | 424 Million USD | 121.09% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -3.779% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -15671.252% |
| XBiotech Inc. | -1.74 Million USD | -5027.466% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7970.668% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -92.428% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -18.388% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 221.825% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 632.185% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 122.986% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -80.118% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 127.367% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -689.688% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 465.723% |
| NexImmune, Inc. | -1.02 Million USD | -8624.433% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1656081.481% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1158.476% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.791% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -133712.681% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2418.248% |
| Ainos, Inc. | -253.73 Thousand USD | -35142.952% |
| Pluri Inc. | 322 Thousand USD | 27871.118% |
| Prothena Corporation plc | -129.2 Million USD | 30.788% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 277.342% |
| Celularity Inc. | 6.75 Million USD | 1423.805% |
| Rallybio Corporation | -150 Thousand USD | -59515.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -174.245% |
| MeiraGTx Holdings plc | 287 Thousand USD | 31257.84% |
| Omeros Corporation | -69.77 Million USD | -28.152% |
| Humacyte, Inc. | -76.55 Million USD | -16.816% |
| Immunocore Holdings plc | 248.39 Million USD | 136.001% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -489.512% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 243.347% |
| Blueprint Medicines Corporation | 236.58 Million USD | 137.798% |
| CalciMedica, Inc. | -58 Thousand USD | -154077.586% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -6170.898% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -3044.269% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -189.723% |
| Pulmatrix, Inc. | -8.22 Million USD | -987.871% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -7542.991% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -22311.779% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 77.577% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 3321.771% |
| Cytokinetics, Incorporated | -322.59 Million USD | 72.28% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 10472.634% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -26123.754% |
| Vor Biopharma Inc. | -3.49 Million USD | -2460.796% |
| Roivant Sciences Ltd. | 109.23 Million USD | 181.863% |
| Evogene Ltd. | 1.39 Million USD | 6491.923% |
| ProKidney Corp. | -3.16 Million USD | -2721.805% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -103.641% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1404.113% |
| CorMedix Inc. | -205.56 Thousand USD | -43401.717% |
| BioLineRx Ltd. | 1.1 Million USD | 8170.668% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -13.667% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -270878.788% |
| Atai Life Sciences N.V. | -5000.00 USD | -1788360.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -73282.352% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -93048.958% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -6337.941% |
| Sagimet Biosciences Inc. | 2 Million USD | 4571.15% |
| MediciNova, Inc. | 979.7 Thousand USD | 9227.543% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -6.053% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -94472.471% |
| GeoVax Labs, Inc. | -20.72 Million USD | -331.562% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 136.569% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2028.612% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 110.251% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1304.188% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -28746.129% |
| Absci Corporation | -41.84 Million USD | -113.68% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1788360.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -17.087% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -3533.604% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 141.838% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -9402.976% |
| Allakos Inc. | -6.14 Million USD | -1356.163% |
| Imunon, Inc. | -720 Thousand USD | -12319.775% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -29.606% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 118.791% |
| BioAtla, Inc. | -103.73 Million USD | 13.793% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -783762.202% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -50137.64% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 63.173% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -28653.376% |
| XOMA Corporation | 3.86 Million USD | 2416.058% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -27.592% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 704.455% |
| aTyr Pharma, Inc. | -2.38 Million USD | -3644.682% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 817.681% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -308255.172% |
| Viridian Therapeutics, Inc. | -1 Million USD | -8771.329% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 687869330.769% |
| Akari Therapeutics, Plc | -4000.00 USD | -2235475.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 114.041% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 46026.721% |
| UroGen Pharma Ltd. | 73.35 Million USD | 221.909% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -234.993% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 770323.945% |
| Orgenesis Inc. | -5.72 Million USD | -1461.974% |
| Entera Bio Ltd. | -56 Thousand USD | -159583.929% |
| GH Research PLC | -315 Thousand USD | -28288.254% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -47213.757% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -16932.952% |
| Xencor, Inc. | -85.26 Million USD | -4.883% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -40367.107% |
| Replimune Group, Inc. | -2.65 Million USD | -3268.098% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -8831.261% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 150.282% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 46026.721% |
| Portage Biotech Inc. | -54 Thousand USD | -165498.148% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -94472.471% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -23619.629% |
| OncoCyte Corporation | 413 Thousand USD | 21752.058% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1989288.209% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -40280530.631% |
| Purple Biotech Ltd. | -196 Thousand USD | -45523.98% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1097.134% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1014.159% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -756.136% |
| HilleVax, Inc. | -2.15 Million USD | -4047.635% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -92088.66% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -595894.401% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -13286.677% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -388695.652% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1191228.189% |
| Savara Inc. | -44.26 Million USD | -102.031% |
| Curis, Inc. | 9.81 Million USD | 1011.457% |
| Daré Bioscience, Inc. | 2.76 Million USD | 3328.824% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -71559.935% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -5071.949% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -39120.614% |
| BeiGene, Ltd. | 2.07 Billion USD | 104.302% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -3098.362% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 77.625% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 257.746% |
| Erasca, Inc. | -3.73 Million USD | -2296.115% |
| bluebird bio, Inc. | -4.03 Million USD | -2118.933% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -316800.56% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 104.696% |
| DBV Technologies S.A. | 15.72 Million USD | 668.559% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -316800.56% |
| Moderna, Inc. | 2.15 Billion USD | 104.15% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -9673.005% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1216.95% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -16583.396% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 166.839% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1337.207% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -127.291% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 19.532% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2392.28% |
| MacroGenics, Inc. | 50.52 Million USD | 276.981% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1366.432% |
| Prime Medicine, Inc. | -147.9 Million USD | 39.54% |
| Aditxt, Inc. | -111.66 Thousand USD | -79985.08% |
| Adagene Inc. | 18.11 Million USD | 593.736% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 18424.385% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 163.782% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 156.656% |
| SciSparc Ltd. | 2.19 Million USD | 4172.086% |
| Vericel Corporation | 135.57 Million USD | 165.958% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -356892.295% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -288528.881% |
| Generation Bio Co. | -73.91 Million USD | -20.987% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -20362.929% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 263.721% |
| Invivyd, Inc. | -2.02 Million USD | -4309.418% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 70.276% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -86350.821% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 192.793% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 190.981% |
| ADMA Biologics, Inc. | 88.21 Million USD | 201.366% |
| Clene Inc. | 533 Thousand USD | 16877.298% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 470.908% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -9244.096% |
| GeoVax Labs, Inc. | -20.72 Million USD | -331.562% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 4598.139% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -45919.371% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 279.546% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1160.9% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -10596.531% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 207.203% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 122409.607% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 268.208% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 48.367% |
| Trevena, Inc. | 1.45 Million USD | 6245.911% |
| Surrozen, Inc. | -27.23 Million USD | -228.399% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -25232.295% |
| Cingulate Inc. | -582.91 Thousand USD | -15240.58% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -288361.29% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -353.947% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1181181.374% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -10050.17% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 113.137% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -8950.911% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -158614.636% |
| Kronos Bio, Inc. | 1.37 Million USD | 6617.711% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -66.629% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -30524.315% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -18212.602% |
| ImmunityBio, Inc. | -17.89 Million USD | -399.849% |
| Korro Bio, Inc. | -3.63 Million USD | -2363.444% |
| Kineta, Inc. | 5.43 Million USD | 1745.923% |
| BioVie Inc. | -229.37 Thousand USD | -38885.164% |
| Codexis, Inc. | 57.33 Million USD | 255.969% |
| Celularity Inc. | 6.75 Million USD | 1423.805% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2328.333% |
| Celcuity Inc. | -142.77 Thousand USD | -62533.43% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 176860.229% |
| Cibus, Inc. | 1.42 Million USD | 6388.537% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -23809.893% |
| IN8bio, Inc. | -2.5 Million USD | -3475.49% |
| Kodiak Sciences Inc. | -25.94 Million USD | -244.637% |
| Annexon, Inc. | -3.26 Million USD | -2637.159% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -4274.902% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -114.254% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 14072.344% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 111.486% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 151.703% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -4606.474% |
| Arcellx, Inc. | 108.27 Million USD | 182.586% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -176.261% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 212.902% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -322.764% |
| Moolec Science SA | -143.3 Thousand USD | -62300.475% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -111.312% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2820.505% |
| Royalty Pharma plc | 1.79 Billion USD | 104.985% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -27.583% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2475619.823% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 38745.842% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 19.738% |
| Humacyte, Inc. | -76.55 Million USD | -16.816% |
| 89bio, Inc. | -273 Thousand USD | -32655.678% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -7014.002% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -10445.165% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -72601.626% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 8091.332% |
| Notable Labs, Ltd. | 113 Thousand USD | 79235.398% |
| Liquidia Corporation | 14.6 Million USD | 712.486% |
| Mustang Bio, Inc. | -2.22 Million USD | -3919.011% |
| Immunovant, Inc. | -231 Thousand USD | -38611.255% |
| Quantum-Si incorporated | 488 Thousand USD | 18424.385% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -60.951% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -297976.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 4902.524% |
| Acasti Pharma Inc. | -11 Thousand USD | -812836.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -43602.625% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -13690.184% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 46.617% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 7981.595% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -23370.604% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -4467.058% |
| PepGen Inc. | -1.18 Million USD | -7452.618% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -70311.811% |
| United Therapeutics Corporation | 2.07 Billion USD | 104.32% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -290.545% |
| Solid Biosciences Inc. | -76.56 Million USD | -16.797% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -108182.576% |
| Immuneering Corporation | -764.13 Thousand USD | -11602.467% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 135049.596% |
| Belite Bio, Inc | -399 Thousand USD | -22311.779% |
| XOMA Corporation | 3.86 Million USD | 2416.058% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -346.312% |
| Bionomics Limited | -434.44 Thousand USD | -20483.083% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -8226.164% |
| uniQure N.V. | 2.21 Million USD | 4137.156% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 2.874% |
| Forte Biosciences, Inc. | -9000.00 USD | -993488.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -10609.341% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -20362.929% |
| Altimmune, Inc. | -65.37 Million USD | -36.789% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 124.7% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -8226.164% |
| Compugen Ltd. | 31.45 Million USD | 384.289% |
| Peak Bio, Inc. | 367.76 Thousand USD | 24414.991% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 464.754% |
| Benitec Biopharma Inc. | 108 Thousand USD | 82899.074% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -114544.872% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -7333.333% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -4807.958% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -75045.378% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -7333.333% |
| Instil Bio, Inc. | -4.75 Million USD | -1780.214% |
| argenx SE | 1.1 Billion USD | 108.067% |
| Immunome, Inc. | -8.9 Million USD | -903.963% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -4631.376% |
| Verona Pharma plc | -679.62 Thousand USD | -13057.717% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -50998.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | -3649.392% |
| CervoMed Inc. | -1.29 Million USD | -6812.58% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -3615.123% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1771.949% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 3718.899% |
| Moolec Science SA | -143.3 Thousand USD | -62300.475% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -21815.791% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -3247.26% |
| Design Therapeutics, Inc. | -537 Thousand USD | -16552.328% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -20842.155% |
| NeurAxis, Inc. | 2.15 Million USD | 4246.281% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 4266.962% |
| Lumos Pharma, Inc. | 2 Million USD | 4555.556% |
| Achilles Therapeutics plc | -4.73 Million USD | -1790.043% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -50998.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -84520.771% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 382.459% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 10472.634% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -8565.019% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -96.327% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 208060.465% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -10778.71% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -679509.363% |
| Palisade Bio, Inc. | 246 Thousand USD | 36450.813% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -270878.788% |
| Beam Therapeutics Inc. | -59.67 Million USD | -49.858% |
| Neurogene Inc. | -3.26 Million USD | -2641.355% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 164.178% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 323.558% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -30008.754% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2120.566% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -834.8% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 735.107% |
| Athira Pharma, Inc. | -969 Thousand USD | -9128.38% |
| Vaccinex, Inc. | -16 Million USD | -458.754% |
| HCW Biologics Inc. | -574.82 Thousand USD | -15456.588% |
| XOMA Corporation | 3.86 Million USD | 2416.058% |
| Nektar Therapeutics | 53.47 Million USD | 267.215% |
| Arvinas, Inc. | 71.8 Million USD | 224.545% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -7.143% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -42.45% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -27671.118% |
| Rezolute, Inc. | -36 Thousand USD | -248297.222% |
| Clene Inc. | 533 Thousand USD | 16877.298% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -6964308.1% |
| BeyondSpring Inc. | 1.75 Million USD | 5206.967% |
| Synlogic, Inc. | -1.92 Million USD | -4547.765% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -241583.784% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1312.239% |
| Peak Bio, Inc. | 367.76 Thousand USD | 24414.991% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -371.566% |
| Krystal Biotech, Inc. | 47.6 Million USD | 287.844% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 163.38% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1879.562% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -3353.667% |
| MannKind Corporation | 136.19 Million USD | 165.66% |
| Ikena Oncology, Inc. | -50.49 Million USD | -77.103% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 182.18% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1939.293% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -35385.317% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1788360.0% |
| Legend Biotech Corporation | 140.92 Million USD | 163.453% |
| Mural Oncology plc | -2.56 Million USD | -3383.561% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -16129.22% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -89323.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 530.871% |
| REGENXBIO Inc. | 53.02 Million USD | 268.63% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1569.288% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -46383.691% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -5062.991% |
| Vaxart, Inc. | -60.76 Million USD | -47.167% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -33929.607% |
| Cellectis S.A. | 18 Thousand USD | 496894.444% |
| Longeveron Inc. | 221 Thousand USD | 40562.896% |
| Repare Therapeutics Inc. | -80.07 Million USD | -11.681% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 108.181% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -6810.587% |
| Revolution Medicines, Inc. | -399.66 Million USD | 77.625% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -255394.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 182595.918% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.039% |
| Denali Therapeutics Inc. | -93.34 Million USD | 4.202% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -356892.295% |
| Veru Inc. | 7.56 Million USD | 1281.917% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -59120.53% |
| Cingulate Inc. | -582.91 Thousand USD | -15240.58% |
| Passage Bio, Inc. | -3.72 Million USD | -2303.198% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -742369.279% |
| Exicure, Inc. | -1.42 Million USD | -6184.118% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -23248.042% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 3408.287% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -17342.434% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 231.261% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -59671.936% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -51.037% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 22970.332% |
| OmniAb, Inc. | 14.66 Million USD | 709.688% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 547.272% |
| Lipocine Inc. | -2.85 Million USD | -3036.749% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -4752.035% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1467.45% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5836.635% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 218.73% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -137473.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 206.082% |
| Ocugen, Inc. | -33.53 Million USD | -166.64% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -2728.052% |
| Q32 Bio Inc. | 578 Thousand USD | 15571.107% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -33644.528% |
| Alumis Inc. Common Stock | -1.28 Million USD | -6864.408% |
| Equillium, Inc. | 35.95 Million USD | 348.687% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -5138.606% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 17960.346% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2163010.789% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -34426.255% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 21254.592% |
| Dominari Holdings Inc. | 2.03 Million USD | 4485.63% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -48639.583% |
| vTv Therapeutics Inc. | -13.59 Million USD | -557.764% |
| Bio-Techne Corporation | 773.07 Million USD | 111.567% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 616.329% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 119.407% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -7549.53% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -272.907% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 864.495% |
| Nkarta, Inc. | -5.86 Million USD | -1423.65% |
| BioCardia, Inc. | -7.24 Million USD | -1133.591% |
| Iterum Therapeutics plc | -1.75 Million USD | -5009.886% |